Table 5.
Analysis of FEV1%Pred Decline in Relation to Inflammatory Markers, With Allowance for Smoking, Gender, and High Starting FEV1%Pred
Parameters* | Annual Decline in Low Group, %/yr† | Additional Decline in FEV1%Pred in the High Group | ||||
---|---|---|---|---|---|---|
%/yr | 95% CI | p Value | Obs‡ | No. | ||
Fibrinogen, ≥ 3.95 g/L (plasma) | − 0.78 | − 0.40 | − 0.72 to − 0.08 | 0.014 | 3,019 | 129 |
IL-6 ≥ 99.6 pg/mL (sputum) | − 0.73 | − 0.42 | − 0.77 to − 0.07 | 0.018 | 2,280 | 88 |
IL-8 ≥ 3,125 pg/mL (sputum) | − 0.79 | − 0.28 | − 0.65 to 0.09 | 0.142 | 1,877 | 68 |
Bacteria > 7.7 (log units) | − 0.76 | − 0.51 | − 0.88 to − 0.13 | 0.008 | 1,977 | 75 |
Neutrophil count ≥ 1.82 × 106 per gram of sputum | − 0.33 | − 0.97 | − 1.45 to − 0.49 | < 0.001 | 1,290 | 45 |
Eosinophil count ≥ 25 × 103 per gram of sputum | − 0.45 | − 0.76 | − 0.13 to − 0.26 | 0.003 | 1,290 | 45 |
Including cut-off for inclusion in the high group.
The low groups contained patients whose initial stable values did not reach the cut-off.
No. of FEV1%Pred observations.